Phase IV, Open Label Trial to Evaluate Immunogenicity of Tdap Vaccine in Post-Partum Women to Optimize Vaccination Schedule for Women Who May Have a Subsequent Child
Phase of Trial: Phase IV
Latest Information Update: 09 May 2017
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics; Therapeutic Use
- 23 Mar 2017 Status changed from active, no longer recruiting to completed.
- 12 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Apr 2013 Planned End Date (Oct 2015) added as reported by ClinicalTrials.gov.